baclofen

(redirected from Colazal)
Also found in: Medical.
Related to Colazal: Colazide

bac·lo·fen

 (băk′lə-fĕn)
n.
A drug, C10H12ClNO2, that acts as a gamma-aminobutyric acid receptor agonist and is used to treat muscle spasticity, especially in patients with multiple sclerosis and spinal cord injuries.

baclofen

(ˈbækləʊˌfɛn)
n
a muscle-relaxing drug used to treat muscle spasms
Translations

baclofen

n baclofeno
References in periodicals archive ?
We believe the combined effort of the Salix and Eisai sales and marketing teams provides a strategic opportunity for us, in the near term, to expand our COLAZAL business, and, in the longer term, to expedite the introduction and growth of our pending balsalazide tablet product," stated Carolyn Logan, President and Chief Executive Officer, Salix.
Our 750 mg capsule formulation of balsalazide disodium, which we market in the United States under the trade name COLAZAL, has experienced steady market acceptance and growth since we launched it in 2001.
During the second half of October approximately 600 Eisai sales representatives began promoting COLAZAL as a result of our recently announced balsalazide co-promotion agreement.
Carolyn Logan, President and Chief Executive Officer, stated, "Salix is committed to aggressively protecting its COLAZAL business and growing market share in the inflammatory bowel disease market.
For more information about COLAZAL, please contact Salix at 919-788-8550 or visit our web site at www.
On May 14, 2003, Salix management announced that it estimates approximately $53 million in net Colazal sales for 2003 - a 58% increase over 2002 sales.
The report points to two specialty pharmaceutical product launches, Salix Pharmaceutical's Colazal for the treatment of acute ulcerative colitis and InKine Pharmaceutical's Visicol (formerly Diacol) a colonic purging agent for use prior to colonoscopy, as potential value drivers in the gastroenterology market in 2001.
Safety and effectiveness of COLAZAL beyond 12 weeks has not been established.
Safety and effectiveness of COLAZAL (balsalazide disodium) Capsules 750 mg beyond 8 weeks in children (ages 5-17 years) and 12 weeks in adults has not been established.
COLAZAL (balsalazide disodium) Capsules 750 mg, is an anti-inflammatory drug approved for the treatment of mildly to moderately active ulcerative colitis.
Raleigh, North Carolina, announced that the FDA granted Colazal (balsalazide) additional marketing exclusivity until January 8, 2007.
This is devastating news for Salix, as Colazal was a significant contributor to both the top-and bottom-line.